Abstract
The rapid development of COVID-19 vaccines and their deployment in less than a year is an unprecedented scientific, medical, and public health achievement. This rapid development leveraged knowledge from decades of HIV/AIDS research and advances. However, the search for an HIV vaccine that would contribute to a durable end to the HIV pandemic remains elusive. Here, we draw from the US government experience and highlight lessons learned from COVID-19 vaccine development, which include the importance of public-private partnerships, equitable inclusion of populations impacted by the infectious pathogen, and continued investment in basic research. We summarize key considerations for an accelerated and re-energized framework for developing a safe and efficacious HIV vaccine.
【초록키워드】 public health, HIV, HIV/AIDS, COVID-19 vaccine, pandemic, knowledge, Population, pathogen, HIV vaccine, Research, Safe, Government, COVID-19 vaccine development, Inclusion, highlight, include, less, contribute, accelerated, impacted, key consideration, 【제목키워드】 HIV, COVID-19 pandemic,